Medi Assist Healthcare Services: A Deep Dive!

Unpacking the real business behind the claim form | ZN Research Lab #51

One of the most underrated ways to understand a business is through an open-ended conversation. There is a reason why podcasts, interviews, and long-form discussions have become powerful learning tools. When people think aloud, challenge assumptions, ask seemingly naïve questions, and build on each other’s ideas, insights often emerge that would never appear in a conventional report or presentation. A business is rarely just a collection of financial statements, ratios, and management commentary. It is a story of incentives, people, industry structure, strategy, technology, competition, and evolution. Over the years, some of our deepest learnings have come from discussing a business at length and exploring it from multiple angles. That thought led to an experiment. I decided to approach this blog as an open conversation between the three co-founders of Zen Nivesh, Shivam, Harshal, and Ankit (that’s me). The objective was to determine whether asking better questions could lead to a deeper understanding of the business.

So, let’s get started on Medi Assist.

Ankit: The more I studied Medi Assist, the more I felt I was making the same mistake I had made multiple times before.

Shivam: Which is?

Ankit: Looking at the company through the lens of the label rather than the function. When you hear the words “Third Party Administrator, “ you immediately stop thinking. It’s almost as if the label itself kills curiosity. We hear ‘insurer,’ and our minds start thinking about insurance companies. You hear ‘hospital,’ and your mind starts thinking about healthcare providers. You hear ‘software,’ and your mind starts thinking about SaaS businesses. But you hear TPA, and somehow your brain files it under operational outsourcing and moves on.

Harshal: Fair enough. If somebody tells me they manufacture rockets, I become curious. If somebody tells me they process insurance claims, I move on.

Ankit: That’s precisely the problem. Let me put it differently. Suppose that tomorrow morning, every hospital in India continues to function. Every doctor continues working. Every insurer continues underwriting policies. Every patient continues paying premiums. But the layer connecting them all suddenly disappears. The cashless approvals, claim adjudication, hospital network relationships, fraud detection systems, discharge coordination, and reimbursement workflow. All of them disappear at once. The communication bridge between insurers and hospitals goes missing. What happens?

Shivam: Chaos.

Harshal: More importantly, everybody starts blaming everybody else. The patient blames the hospital. The hospital blames the insurer. The insurer blames the hospital. And nobody knows where the problem actually resides.

Ankit: True. That is why I think we should not see it just as a claims processor. It is a whole infrastructure. When infrastructure works, nobody notices that. We only notice it when it breaks. Think about electricity, payment systems, roads, or internet connectivity. Nobody wakes up appreciating them every day. But remove them and suddenly society stops functioning smoothly.

Harshal: So you’re saying Medi Assist is to healthcare insurance what plumbing is to a building.

Ankit: That’s actually a good analogy. Nobody buys a house because of the plumbing. But if the plumbing stops working, nothing else matters. And that naturally led me to another question. How does a company like this get built? Because nobody starts a business saying, “Let’s become India’s largest healthcare claims administrator.” There has to be a story behind it. And that’s where Medi Assist became far more interesting than I expected.

Shivam: This is where the Reliance group comes into play?

Ankit: Yes. But before Reliance, let’s talk about something else. Spin-offs. Not legal spin-offs. Economic spin-offs. Because I genuinely think Medi Assist resembles some of the best spin-off situations we’ve studied, even though technically it wasn’t one.

Harshal: Explain.

Ankit: Think about what creates opportunity in a spin-off. Most people focus on the transaction. The demerger. The listing. The shareholder distribution. But that’s not what creates value. The real value comes from attention. A small business sits inside a large organization. Management attention goes elsewhere. Capital allocation goes elsewhere. Analyst coverage goes elsewhere. Investor interest goes elsewhere. The business itself may be perfectly fine. It simply isn’t important enough. Then one day the business gets separated. And suddenly, people discover something that had been sitting there all along.

Shivam: So where does Medi Assist fit into this framework?

Ankit: Through Reliance. Imagine being Reliance. The mota bhai ka chota bhai wala Reliance. Think Anil Ambani. You’re looking at telecom, energy, financial services, and infrastructure. Massive capital allocation decisions. Massive industries. Massive opportunities. Now compare that to a company coordinating health insurance claims. Even if the business is good, it is tiny relative to everything else happening around it. Within that ecosystem, Medi Assist will never be the center of attention.

Harshal: Which means the issue wasn’t necessarily the quality of the business. It was the context within which the business existed.

Ankit: Exactly. That’s why I find the Reliance origin fascinating. Because the business didn’t suddenly become better the day Reliance exited. What changed was ownership, focus, and incentives. And sometimes that’s enough to unlock an entirely different trajectory.

Shivam: That’s actually a common pattern in investing. A business becomes valuable not because something new is created, but because something that already exists finally receives the attention it deserves.

Ankit: If you trace the transaction chain involving Reliance Capital, Reliance Health Ventures, Medybiz, Medimatter, and Medi Assist for the period around 2010 and 2011, you’ll see it as the moment the business stopped being a side project and became somebody’s life’s work.

Harshal: That’s interesting. A side project becoming somebody’s life’s work.

Ankit: Think about it. Inside a conglomerate, Medi Assist was one among many businesses. Outside, every insurer relationship, every hospital, every claim, every process improvement, and every customer mattered. The exact same business was suddenly receiving a completely different level of attention. And then Bessemer enters. We know Bessemer entered years before the IPO. Their acquisition price was dramatically lower than the eventual IPO price. They waited years of private-market evolution. VC/PE investors usually don’t spend a decade backing businesses they don’t understand.

Harshal: Especially not boring businesses.

Ankit: Haha! :) Let’s imagine India around that period. Health insurance penetration is low. Healthcare costs are rising. The middle class is expanding. Employer-sponsored insurance is becoming more common. Private hospitals are scaling. Medical inflation is outpacing general inflation. Now ask yourself a simple question. As more insurance policies get sold, does the system become simpler or more complex?

Shivam: More complex.

Ankit: Yes. More claims. More hospitals. More approvals. More disputes. More fraud. More documentation. More coordination. More data. Complexity increases. And complexity often creates opportunity for intermediaries.

Harshal: Now I get it. Medi Assist benefits from the growth of the entire ecosystem regardless of which insurer wins.

Ankit: Exactly. They’re enablers. Insurance companies take underwriting risk. Hospitals take operating risk. Patients take health risk. Medi Assist coordinates the system to enable risk-taking.

Now let’s talk about Dr. Vikramjit Chhatwal. Businesses are ultimately reflections of the people building them. Dr. Chhatwal isn’t a traditional promoter. He’s not a software founder. He’s not a financial engineer. He’s not a career investor. He’s a doctor. Healthcare looks very different depending on where you’re standing. A hospital administrator sees healthcare differently from a doctor. An insurer sees healthcare differently from a patient. A regulator sees healthcare differently from a hospital owner. Dr. Chhatwal’s background gave him exposure across multiple layers of the ecosystem. Medicine. Healthcare administration. Apollo. Reliance. Insurance. Operations. When I look at Medi Assist today, I increasingly think the company reflects that perspective.

Harshal: Ok. Most companies want to dominate a layer. Medi Assist seems to want to connect layers.

Ankit: Yes. And that makes sense. Businesses that connect layers can become surprisingly powerful. Because every participant benefits from their existence. The hospital benefits. The insurer benefits. The employer benefits. The patient benefits. The question then becomes: How do you scale a business built around coordination? And that’s where the next character enters the story. Satish Gidugu. Because if Dr. Chhatwal helped build the company, Satish helped transform it. And honestly, that’s where Medi Assist’s story begins to move from healthcare administration into something much deeper.

Shivam: You said that if Dr. Chhatwal helped build Medi Assist, Satish helped transform it. What’s the difference?

Ankit: The difference is the same difference between building a road and building a highway network. The first creates connectivity. The second creates scale. I think that’s the easiest way to understand what happened inside Medi Assist over the last decade. By the time Satish entered the picture, the company had a few prized possessions and forms of ownership. It had relationships with insurers, hospitals, and corporations. It had claims data, credibility, and operational experience. But it was still largely a people-driven organization. And that’s natural. Historically, almost every TPA in India was people-driven. Now imagine what happens when health insurance penetration, healthcare inflation, and claim volumes increase, hospitals expand across India, and insurers acquire millions of customers. The complexity explodes. At some point, you hit a very simple problem. Adding more people stops solving the problem. You need systems.

Harshal: That’s true in most industries. At the beginning, effort solves problems. At scale, systems solve problems.

Ankit: True. And that’s where Satish becomes important. Look at his background. SAP. Intergraph. redBus. These are not healthcare administration companies. These are businesses that achieve scale through systems. And when somebody with that background enters a business like Medi Assist, the questions naturally change. You stop asking: “How many people do we need?” And you start asking: “Why does this process need a person at all?” You stop asking: “How can we process more claims?” And you start asking: “Why are claims taking so long to process?” You stop asking: “How can we hire more people?” And you start asking: “What part of this workflow can become software?”

Shivam: That’s actually a subtle but powerful shift. One mindset scales through manpower. The other scales through architecture.

Ankit: Yes. And when I studied Medi Assist’s evolution, I increasingly felt I was looking at a company slowly moving from manpower to architecture. Now let’s think about the claims process itself. We tend to assume healthcare is about doctors. But from an operational perspective, healthcare is information moving between different entities. The doctor knows one thing. The hospital knows another. The insurer knows another. The patient knows another. The TPA is in the middle trying to make sense of everything. That means every claim is essentially an information problem.

Harshal: That’s actually fascinating. Most people think healthcare is a medical problem. You’re saying a large part of healthcare administration is an information problem.

Ankit: Exactly. Let’s take a simple example. A patient gets admitted. The hospital estimates one treatment cost. The insurer wants validation. The policy has certain exclusions. The patient doesn’t know what is covered. The hospital doesn’t know how the insurer will interpret something. The insurer doesn’t know whether the hospital estimate is reasonable. Now multiply that by millions of claims. You have an information-processing system. And that’s where data becomes important. Very important. In fact, I would argue that data is arguably one of the most misunderstood aspects of Medi Assist’s business.

Shivam: Let’s explore that. Because I think that’s where the moat discussion begins.

Ankit: Actually, yes. The value of a claim isn’t necessarily in processing that claim. The value may lie in what the next million claims teach you.

Harshal: That’s a very different way of looking at it. You’re saying claims are not just transactions. They’re observations.

Ankit: Of course. And observations compound. I don’t see claims volume as an operating metric alone. I increasingly see claims volume as a learning metric. Because every additional claim improves the company’s understanding of the healthcare ecosystem. Think about fraud.

Suppose one hospital starts exhibiting unusual behavior. Maybe certain procedures are occurring more frequently than usual. Maybe pricing patterns are different. Maybe there are strange admission trends. The hospital itself won’t notice. The insurer may not notice. But a company that observes thousands of hospitals and millions of claims suddenly has context. Fraud detection is all about recognizing patterns.

Shivam: Which means scale itself becomes a competitive advantage. Not because you’re bigger. Because you’re smarter.

Ankit: That’s a good way to put it. When management talks about MAven Guard identifying hundreds of crores of potential fraud, don’t treat it like a product announcement. It is evidence that data is beginning to create economic value. Because every rupee of fraud prevented eventually benefits somebody. The insurer benefits. The policyholder benefits through lower premium pressure. The employer benefits. The ecosystem benefits. And the more successful you become at fraud detection, the more valuable you become to insurers.

Harshal: Which creates trust.

Ankit: 100%. And trust is a recurring theme throughout Medi Assist. That trust wasn’t built in one year. It was built claim by claim. Relationship by relationship. Hospital by hospital. Insurer by insurer. That’s why I don’t think this is an easy business to replicate. You may say, “How difficult can claims administration really be?” I think that’s the wrong question. The right question is: How long would it take a new entrant to build the trust network that Medi Assist has spent decades building? And that’s a much harder question to answer.

Shivam: Let’s talk about the group business. Because every time I look at the company, I keep coming back to group insurance. It feels like the center of gravity.

Ankit: It absolutely is. In fact, I think understanding Medi Assist becomes much easier once you understand the role group insurance plays in the entire system. It is beyond the revenue stream. Group insurance is the engine that powers everything else. And if it doesn’t work, the employer hears about it immediately. Which means employers care deeply about service quality.

Harshal: Makes sense. Nobody complains about health insurance when they’re healthy. That is saved for the time when something goes wrong.

Ankit: Exactly. Healthcare is one of those industries where the moment of truth matters enormously. The policy document is irrelevant if the experience breaks during hospitalization. And that’s why retention becomes such an important metric. When you see 94% or 95% retention, think of it as proof that thousands of employers continue to trust the system.

Shivam: So the group business isn’t just revenue. It’s data. It’s relationships. It’s trust. It’s learning. It’s distribution.

Ankit: And that’s why I often call it the fortress. Everything else can evolve. Everything else can change. But the group business is the foundation upon which the rest of the company is being built. Maybe Medi Assist’s future isn’t about becoming a bigger TPA but about becoming something even deeper within the healthcare workflow. And that’s where products like Matrix, Navigator, Prime, and the broader platform strategy start becoming important. Because once you’ve spent twenty years building trust, data, and relationships, the natural question becomes: What else can you build on top of that foundation?​

Harshal: The last thing you said has been stuck in my head. “What else can you build on top of that foundation?” Once you’ve built trust, distribution, relationships, and data, then what? Do you simply keep doing more of the same? Or do you use those assets to build something bigger?

Ankit: Very well put. Because if the company wanted to remain a traditional TPA, the playbook was fairly straightforward. Acquire more clients. Process more claims. Expand hospital networks. Improve operational efficiency. Generate cash. Repeat. There is nothing wrong with that model. In fact, it is likely to continue growing for years as India’s health insurance market expands. But when I look at management commentary over the last few years, I don’t think that’s the ambition anymore. The language itself has changed. Five years ago, management largely talked about claims administration. Today they increasingly talk about healthcare administration. Benefits administration. Fraud intelligence. Provider enablement. Workflow infrastructure. Predictive analytics. That’s not accidental. The words changed because the company itself is evolving.

Shivam: Let’s explore that carefully. Because sometimes management changes language faster than reality changes. Every company eventually starts talking about platforms. Very few actually become one.

Ankit: Completely agree. Which is why we should ignore the labels and focus on the economics. Let’s take MAtrix. I think MAtrix may be one of the most important developments. Historically, if an insurer wanted to handle claims administration, it would either build internal capabilities or outsource to a TPA. That’s the old world. In that world, Medi Assist either wins the mandate or loses the mandate. Binary outcome. But MAtrix changes that. Now imagine an insurer saying: “We want to retain control.” “We don’t want a TPA.” “We want in-house administration.” Traditionally, Medi Assist would lose that business. Today that’s no longer necessarily true. The insurer can keep control while using Medi Assist’s infrastructure. That is a completely different economic model.

Harshal: It’s almost like the difference between hiring a driver and buying GPS software. One is outsourced execution. The other is infrastructure.

Ankit: Your analogies are spot on, Harshal. And infrastructure tends to scale differently. Because now the company can participate even when it doesn’t own the entire relationship. Think about what that does to the addressable market. Suddenly the question is no longer: “How many TPA mandates can we win?” The question becomes: “How many healthcare workflows can we touch?” Very different question. Very different opportunity.

Shivam: But is there evidence that insurers actually want this? Or are we projecting our own narrative?

Ankit: That’s a fair challenge. The evidence is still evolving. But there are clues. Management repeatedly mentions insurers using MAtrix. Claims being processed through MAtrix. Technology revenue growing much faster than traditional revenue. Private insurers increasingly using parts of the stack. None of this proves a platform transformation. But it does suggest movement in that direction. And that’s why I think we need to watch technology adoption metrics very closely over the next few years. Because this may eventually determine whether Medi Assist is valued like a services business or more like an IT infrastructure.

Harshal: That’s a huge distinction. Because services businesses usually scale through people. Infrastructure businesses often scale through systems.

Ankit: Also, markets assign very different valuation multiples to those two business models. Now let’s discuss something else that I think is underappreciated. Navigator. At first glance, Navigator sounds like a nice feature. But I think it’s solving a much deeper problem. Let’s imagine you’re about to undergo treatment. What do you actually know? You know you’re sick. You know you have insurance. Beyond that, uncertainty dominates the experience. How much will the treatment cost? What portion is covered? What portion isn’t covered? Will there be a co-pay? Will there be exclusions? Will there be non-medical expenses? Most patients don’t know. And uncertainty creates anxiety.

Harshal: That’s true. People don’t fear bills. They fear surprise bills.

Ankit: Exactly. And that’s why I found Navigator interesting. Because it’s not merely predicting expenses. It’s reducing uncertainty. One recurring theme across Medi Assist’s product suite is its focus on reducing friction. Prime reduces discharge friction. Navigator reduces information friction. MAtrix reduces workflow friction. MAven Guard reduces fraud-related friction. When you look at them collectively, they’re all solving different forms of friction within the healthcare ecosystem.

Shivam: That’s actually an interesting way to frame the company. A friction-reduction company.

Ankit: I know. And businesses that remove friction often become more valuable than they initially appear. Because every participant benefits. Hospitals benefit. Insurers benefit. Employers benefit. Patients benefit. Charlie Munger would call it a perfect example of a win-win model.

Now let’s talk about government business. Because I initially struggled with this segment. On one hand, it’s huge. Millions of beneficiaries. Large schemes. Massive scale. On the other hand, it behaves very differently from the rest of the company. Government contracts bring complexity. Tender dependence. Operational intensity. Lower margins. Political and regulatory dependencies. So, I don’t view government business as the future growth engine. I view it as something else.

Shivam: What?

Ankit: Proof of capability. If a company can administer healthcare benefits for crores of beneficiaries under government schemes, it speaks to operational capability. The economics may not be extraordinary. But it provides credibility.

Harshal: So government business is less about margin and more about demonstrating competence.

Ankit: Bang on. And then there’s international business. Mayfair. At first glance, it looks small. And relative to domestic operations, it is. But it introduces a different possibility. Indian companies becoming increasingly global, employees moving across geographies, healthcare benefits becoming more international, and multinational corporations seeking a single integrated administration layer. Mayfair creates optionality. And sometimes optionality becomes valuable later than people expect.

Shivam: So if we zoom out, we now have four pieces. Group business. Technology. Government. International. How do you rank them?

Ankit: Today? Group remains the fortress. Technology is the future. Government is scale. International is optionality. That’s how I think about it. The market is probably valuing the business only based on the fortress. The future upside probably depends on the second piece. Technology. Because if MAtrix and related products are genuinely embedded in insurer workflows, the company’s economics may gradually change.

Harshal: Which brings us back to a question we touched on earlier. What is Medi Assist actually becoming?

Ankit: That can not be answered in a straight line. Because every year I become less comfortable calling it a TPA. Not because the TPA business is disappearing. The TPA business remains the foundation. But because more layers keep being added to that foundation. The claims administration layer still exists. It’s still critical. It’s still the foundation. But over time, additional layers are being built on top of it. Data. Fraud intelligence. Workflow software. Hospital enablement. Predictive analytics. Healthcare administration tools.

Shivam: That’s a good place to pause. So far, we’ve discussed the business, the industry, and the evolution. But we haven’t yet discussed something equally important. Execution. Because plenty of companies have great stories. Very few actually deliver.

Ankit: Sure. While we cannot connect the dots looking forward, we can connect the dots looking backward. Over the last decade, did management actually do what it said it would do? Because that’s where credibility gets built. Or destroyed.​

Shivam: That’s where I want to slow down. Because this is the part where most investment stories either become stronger or fall apart. The story can be beautiful. The industry can be large. The language can be impressive. But eventually we have to ask: Did management say something and then actually do it?

Ankit: Exactly. Say-Do ratio is one of the cleanest ways to study Medi Assist. Because the company has now provided us with sufficient public material. DRHP. Annual reports. Investor presentations. Quarterly calls. Acquisition-related commentary. So we can actually compare the evolution of language with the evolution of numbers.

Harshal: Let’s start with the biggest claim. Were they really the leader?

Ankit: Yes. That was not vague storytelling. At the pre-IPO stage itself, Medi Assist positioned itself as India’s largest Health Benefits Administrator by revenue, EBITDA, PAT, and premium serviced among TPAs. The leadership in this business is not just a vanity point. Leadership creates scale. Scale creates claims data. Claims data improves fraud detection. Fraud detection improves insurer value. Insurer value improves retention. Retention improves future cash generation. So, when they said they were the leader, it wasn’t merely a ranking. It was the foundation of the business model.

Shivam: And after listing?

Ankit: They retained and expanded that leadership, especially in group. Premium under management grew significantly. Hospital network expanded. Claims processed increased. Group market share improved. So, the leadership claim was not just preserved; it was strengthened.

Harshal: What about group insurance? Because, from everything we’ve discussed, that seems to be the real heart of the business.

Ankit: Group insurance is the clearest proof of execution. Management consistently emphasized group health as the core engine. And the numbers support it. Group premiums kept growing. Market share remained strong. Retention remained above 90%. Corporate relationships expanded. Once a large corporate integrates its employee health insurance workflow with a TPA, switching is possible but not painless. Employees and HR teams know the system. Hospitals are mapped. Claims history exists. Escalation pathways exist. Data exists. So, high retention is a sign that the company has embedded itself into corporate health benefits workflows.

Shivam: That’s important. Because in many businesses, customer retention is a financial metric. Here it’s an operating moat metric.

Ankit: True.

Harshal: What about technology? This is where I always worry. Because nowadays every annual report mentions technology, AI, analytics, platforms, and digital transformation. Half the time it’s just vocabulary inflation.

Ankit: That’s a valid concern. And that’s why I don’t want to give Medi Assist credit just for using the word AI. The question is whether technology is showing up in operational metrics. And I think it is. Claim volumes increased without a proportional increase in staff. Insurer integrations increased. Hospitals submitted more claims digitally. Fraud detection numbers became measurable. Products like MAtrix, MAven Guard, Navigator, Prime, and MAgnum were integrated into actual workflows.

Shivam: So the right interpretation is not “Medi Assist is a SaaS company.” The right interpretation is “Medi Assist is a services infrastructure company becoming increasingly software-enabled.”

Ankit: Perfectly put. That’s exactly the distinction. Calling it a pure SaaS company would be wrong. Calling it a traditional TPA would also be incomplete. The company sits in between. And that in-between zone is where both opportunity and confusion lie.

Harshal: Let’s talk about fraud detection again.

Because I think that’s one of the most tangible parts of the technology story.

Ankit: Yes. Fraud detection may be the strongest evidence that technology and data are creating real economic value. When MAven Guard identifies hundreds of crores of potential fraud, that is not just a feature. It’s value creation. Insurers care deeply about claims leakage. Every fraudulent or inflated claim affects loss ratios. If Medi Assist helps control that, it becomes more valuable to insurers. This is why fraud detection is different from a nice app interface. It directly affects economics.

Shivam: And fraud detection improves with more data.

Ankit: Exactly. Which means Medi Assist’s scale feeds its fraud engine. The more claims it sees, the better it can recognize anomalies. The better it recognizes anomalies, the more value it creates for insurers. The more value it creates, the stronger its relationships become. Again, the flywheel shows up.

Harshal: What about the customer-facing products? Prime, Navigator, Consent Feature. Are they meaningful or just experience features?

Ankit: I think they are more meaningful than they appear. Take hospital discharge. A doctor says the patient can go home. But the patient cannot leave because billing, insurance approval, and paperwork are still pending. The patient is tired. The family is anxious. The hospital bed is occupied. The insurer wants verification. The TPA has to coordinate. If Raksha Prime reduces that friction, it creates value for all sides. The patient leaves faster. The hospital releases the bed faster. The insurer gets a smoother claim experience. Medi Assist becomes more embedded in the workflow. That’s why I don’t see Prime as just a feature. I see it as workflow capture.

Harshal: Workflow capture is a good phrase. Because once you’re inside the workflow, you’re harder to replace.

Ankit: Of course. The deeper Medi Assist moves into admission counseling, out-of-pocket prediction, cashless approval and discharge experience, the less it looks like a back-office processor. It starts becoming part of the healthcare journey itself.

Shivam: Let’s move to acquisitions. Because roll-up stories can look very attractive until integration fails.

Ankit: Absolutely. Medi Assist’s acquisition record is one of the most important parts of the thesis. The company said it could acquire and integrate fragmented TPA businesses. The evidence from Raksha and Medvantage suggests they have done this reasonably well. But the important part is how management communicated it. They didn’t pretend acquisitions would instantly improve margins. With Raksha, they openly said margins would be lower initially. They said integration would take time. They said the acquired business would need to migrate onto Medi Assist’s platform. Then over time, contribution improved. That builds credibility.

Harshal: Because they acknowledged pain before claiming benefit.

Ankit: That’s a very underrated management quality. Many management teams sell acquisitions as instantly accretive. Medi Assist seemed more realistic. They said the first few quarters would be messy. Then the benefits of technology, processes, and scale would become apparent. And that broadly happened with Raksha and Medvantage.

Shivam: Paramount is the larger test though.

Ankit: Yes. Paramount is the final exam of the acquisition thesis. It’s large enough to matter. If Paramount integrates well, Medi Assist’s consolidation credibility improves dramatically. If it doesn’t, investors will question whether the earlier acquisitions were easier because they were smaller. Early evidence is encouraging. Paramount’s margin drag has reduced. Claims migration to MAtrix started. Corporate policies began moving to the Medi Assist stack. But I wouldn’t declare victory yet. The real test is whether Paramount achieves acceptable margins after full integration without losing key clients.

Harshal: So the correct view is cautious optimism.

Ankit: You are being politically correct. :)

Shivam: Now let’s discuss financials. Because eventually all this has to show up in numbers.

Ankit: Financially, the business has been healthy. Revenue has grown. EBITDA has grown. Margins have remained respectable, though they have moderated during acquisition integration. The company became debt-free and net cash positive. Acquisition-led growth often carries hidden balance sheet risk. Here, so far, that risk appears controlled.

Harshal: Why does being debt-free matter so much in this case?

Ankit: Because this business requires trust. If you’re administering healthcare benefits, insurers and corporates need confidence that you’re stable. A stressed balance sheet would weaken that confidence. Also, acquisitions create integration uncertainty. If you combine integration uncertainty with leverage, risk compounds. Medi Assist’s debt-free position gives it breathing room. It can invest in technology. It can absorb temporary margin drag. It can integrate Paramount without financial panic. It can pursue future opportunities selectively.

Shivam: But margins have compressed.

Ankit: Correct. Historical EBITDA margins were in the low-20s. FY26 consolidated margin was lower because of Paramount and integration costs. The key question is whether margins recover after integration. If margins don’t recover, the thesis weakens. So, I would track ex-Paramount margin, consolidated margin, technology revenue contribution, and cash conversion very closely.

Harshal: So what are the things management has not yet fully proven?

Ankit: Four things stand out. First, technology revenue materiality. They have shown technology usage. They have not yet shown that technology can become a large revenue stream. Second, retail platform monetization. Platform-managed retail premiums look impressive, but we need to see revenue yield.

Third, Paramount integration. Early signs are good, but final proof is pending. Fourth, ownership alignment. This is the most emotionally uncomfortable part of the story.

Shivam: Let’s go there. Promoter stake.

Ankit: Yes. This is where the story becomes less clean. On the operating side, the company appears to be getting stronger. But on the ownership side, the optics are becoming more complex. The founder-promoter stake has materially reduced. Bessemer and other early investors have monetized and exited. Dr. Chhatwal’s personal stake became negligible. Total promoter holding has reduced significantly. Now, none of this automatically means the business is weak. People sell for many reasons. Funds have lifecycles. Founders diversify. Early investors need exits. These liquidity events are part and parcel of the game. But in India, promoter ownership also matters a lot.

Harshal: Hmm. It is not about numbers. It is about alignment.

Ankit: Exactly. Especially in smaller companies. When promoters own a meaningful stake, we feel that management suffers and benefits alongside us. When that stake reduces, we start doubting. Who is truly carrying the long-term burden of ownership?

Shivam: Management responded by saying Medi Assist is professionally managed, board-driven, not family-run.

Ankit: And that’s a fair response. In fact, it may be the correct way to think about the company. Medi Assist may no longer be a classic promoter-led Indian compounder. It may be evolving into a professionally managed, institutionally governed infrastructure company. That model can work. Many great businesses globally are professionally managed. But the transition needs clarity.

Who owns the culture?

Who protects capital allocation?

Who thinks in decades?

Who resists short-term pressure?

Who carries the emotional ownership?

Those questions matter, but are difficult to answer.

Harshal: Emotional ownership is such an important phrase. Because ownership is not only shareholding. It’s responsibility.

Ankit: So well said. Legal ownership and psychological ownership are different. A CEO with low equity but deep mission ownership can sometimes behave like a founder. A promoter with high equity but low involvement can sometimes behave like a financial investor. So we shouldn’t be simplistic. But we shouldn’t ignore the question either.

Shivam: So how would you summarize Medi Assist after all this?

Ankit: I would say Medi Assist is a business whose label understates its function. The label says TPA. The function says healthcare administration infrastructure. Its core strength comes from group health insurance. Its scale creates data. Its data improves fraud detection. Its fraud detection improves insurer value. Its technology improves workflow. Its workflow embedding improves stickiness. Its acquisitions increase scale and deepen the network. Its balance sheet gives it room to execute. That’s the positive side.

Harshal: And the unresolved side?

Ankit: Technology monetization and ownership clarity. If technology revenue becomes meaningful and promoter-related uncertainty reduces, the market may begin to see Medi Assist differently. If not, it remains a good TPA-led services business, but not necessarily a category-changing platform.

Shivam: So the investment debate is no longer “Is Medi Assist a good business?”

Ankit: Correct. The better debate is: “What kind of good business is it?” A good services business? A good consolidator? A good healthcare infrastructure company? Or an emerging health insurance operating system? Each answer deserves a different valuation.

Harshal: And the market is probably still unsure.

Ankit: That’s why uncertainty is at the center of the story. The real uncertainty is around the company’s next identity. And the next ownership center of the company.

Who controls the journey?

Who carries the burden?

Who ensures technology becomes revenue, not just a narrative?

Who makes sure acquisitions compound and not distract?

Who makes sure professional management behaves with founder-like intensity?

Until we are comfortable with those questions, the stock may struggle to attract the kind of conviction the business otherwise deserves. And that is where I would leave the story. Sometimes the biggest hurdle for a stock is not weak fundamentals. Sometimes it is unresolved identity. What is the company becoming? And who is truly leading it there? Once those two questions are answered, the next journey can begin.

Thanks for reading!
SEBI RIA Disclosure: No holding, no recommendation

---

P.S. We share one deep dive a week on Substack. And a daily read here. The community is free for all. No promotions. No stock tips. Weekdays, daily read from the ZN team. Every weekend for a few hours, the community is open to all who want to share their views or ask questions.